Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.62
+0.03001.89%
Post-market: 1.640.0200+1.23%18:39 EDT
Volume:735.79K
Turnover:1.17M
Market Cap:99.45M
PE:-0.47
High:1.64
Open:1.58
Low:1.51
Close:1.59
Loading ...

Pliant Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
10 Feb

Pliant Therapeutics Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Shares Fall on Drug Trial Pause After Safety Board Review

Dow Jones
·
10 Feb

RBC Downgrades Pliant Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $45, Keeps Speculative Risk

MT Newswires Live
·
10 Feb

Pliant Therapeutics Inc : RBC Cuts to Sector Perform From Outperform

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Suspends Enrollment in Phase 2b Idiopathic Pulmonary Fibrosis Trial

MT Newswires Live
·
10 Feb

Pliant Therapeutics Falls 55.8% Premarket After Co Pauses Enrollment for Lung Disease Treatment Trial

THOMSON REUTERS
·
10 Feb

BUZZ-Pliant pauses enrollment for lung disease treatment trial

Reuters
·
08 Feb

Pliant Therapeutics Shares Down 67% at $2.59 in After the Bell Trading Following Update on Trial for Patients With Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
08 Feb

Pliant Therapeutics trading resumes

TIPRANKS
·
08 Feb

Pliant Therapeutics pauses enrollment, dosing in BEACON-IPF Phase 2b trial

TIPRANKS
·
08 Feb

BRIEF-Pliant Therapeutics Provides Update On BEACON-IPF, A Phase 2B/3 Trial In Patients With Idiopathic Pulmonary Fibrosis

Reuters
·
08 Feb

Pliant Therapeutics Inc - Informing Global Regulatory Authorities

THOMSON REUTERS
·
08 Feb

Pliant Therapeutics Inc - Pauses Enrollment and Dosing in Beacon-Ipf Phase 2B Trial

THOMSON REUTERS
·
08 Feb

Pliant Therapeutics trading halted, news pending

TIPRANKS
·
08 Feb

Pliant Therapeutics Down Nearly 13%, On Track for Lowest Close Since July 2022 -- Data Talk

Dow Jones
·
08 Feb

TD Cowen Sticks to Their Buy Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
23 Jan

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
23 Jan

Pliant Therapeutics Appoints Delphine Imbert, Ph.d. as Chief Technical Officer

THOMSON REUTERS
·
22 Jan

Stock Track | Pliant Therapeutics Shares Plunge Despite Beating Q3 Earnings Estimates

Stock Track
·
09 Nov 2024